The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with obesity.

From sleep apnea-fighting mattresses to smart rings that play lullabies, the best sleep tech from Day 1 of CES 2025 ...

Obstructive sleep apnea (OSA) is a common sleep disorder characterized by intermittent airway blockages during sleep, leading ...

Medicare now covers Eli Lilly's Zepbound for obstructive sleep apnea, FDA-approved for obesity and sleep apnea treatment, ...

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...

The most common form of sleep apnea is obstructive sleep apnea (OSA), which affects nearly a billion people worldwide. It occurs due to a blockage in the upper airway that hinders breathing during ...

Sleep apnea causes people to ... found that those who used it saw reduction in apnea events “This is a major step forward for patients with obstructive sleep apnea,” Dr. Sally Seymour ...

With regular checkups every three to six months, we form trusted relationships ... a condition frequently linked to obstructive sleep apnea. Studies reveal a strong connection between teeth ...

Until now, OSA treatment has focused on mechanical support during sleep in the form of positive airway ... option for certain patients with obstructive sleep apnea," said Sally Seymour, MD ...